Dapsone Tablet
Product Images NDC 64980-567

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 64980-567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dapsone-label-01 (Dapsone Label 01)

This is a description of Dapsone tablets, USP which contain 100 mg of dapsone, used for a variety of skin conditions such as leprosy, dermatitis herpetiformis, and acne. The caution is mentioned that these tablets should not be dispensed without a prescription. The tablets should be stored in a well-closed, light-resistant container with a child-resistant closure, protected from light at controlled room temperature. The manufacturer is Rising Pharmaceuticals, Inc. in East Brunswick, NJ, made in India. The neutral code is 3407600/TS/DRUGS/2022, and was issued in November 2022.*

FDA Label Image

Dapsone-struct (Dapsone Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.